Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)

Go back to Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)

Universal Health Services (UHS) PT Raised to $227 at Cantor Fitzgerald

October 28, 2024 6:38 AM EDT

Cantor Fitzgerald analyst Sarah James raised the price target on Universal Health Services (NYSE: UHS) to $227.00 (from $219.00) while maintaining a Neutral rating.

The analyst comments "We are raising our 12-month price target to $227 from $219. Our 7.9x '26E EV/EBITDA reflects... More

Universal Health Services (UHS) PT Lowered to $211 at RBC Capital

October 28, 2024 6:31 AM EDT

RBC Capital analyst Frank Morgan lowered the price target on Universal Health Services (NYSE: UHS) to $211.00 (from $222.00) while maintaining a Sector Perform rating.

The analyst comments "UHS stock traded off ~10% Friday on elevated buyside expectations with several investors pointing to softer... More

TD Cowen Reiterates Buy Rating on Universal Health Services (UHS)

October 25, 2024 7:49 AM EDT

TD Cowen analyst Ryan Langston reiterated a Buy rating and $283.00 price target on Universal Health Services (NYSE: UHS).

The analyst commented, "Total revenues/adj EBITDA were +1.5%/+1.4% vs consensus. UHS Acute EBITDA was +12.4% above cons, but Behavioral was (8.7%) below; BH revenues were... More

Universal Health Services (UHS) PT Raised to $271 at Barclays

October 25, 2024 7:47 AM EDT

Barclays analyst Andrew Mok raised the price target on Universal Health Services (NYSE: UHS) to $271.00 (from $256.00) while maintaining a Overweight rating.... More

Universal Health (UHS) Misses Q3 EPS by 1c

October 24, 2024 4:19 PM EDT

Universal Health (NYSE: UHS) reported Q3 EPS of $3.71, $0.01 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $3.96 billion versus the consensus estimate of $3.9 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

... More